Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNF╬▒ in glioblastoma.

Kusne Y, Carrera-Silva EA, Perry AS, Rushing EJ, Mandell EK, Dietrich JD, Errasti AE, Gibbs D, Berens ME, Loftus JC, Hulme C, Yang W, Lu Z, Aldape K, Sanai N, Rothlin CV, Ghosh S.

Sci Signal. 2014 Aug 12;7(338):ra75. doi: 10.1126/scisignal.2005196.

PMID:
25118327
[PubMed - in process]
2.

Targeting adaptive glioblastoma: an overview of proliferation and invasion.

Xie Q, Mittal S, Berens ME.

Neuro Oncol. 2014 Jul 30. pii: nou147. [Epub ahead of print] Review.

PMID:
25082799
[PubMed - as supplied by publisher]
3.

Integrated genomic and epigenomic analysis of breast cancer brain metastasis.

Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, Wallstrom G, Tembe W, Baker A, Carpten J, Resau J, Ryken T, Sibenaller Z, Petricoin EF, Liotta LA, Ramanathan RK, Berens ME, Tran NL.

PLoS One. 2014 Jan 29;9(1):e85448. doi: 10.1371/journal.pone.0085448. eCollection 2014.

PMID:
24489661
[PubMed - in process]
Free PMC Article
4.

Detection of an atypical teratoid rhabdoid brain tumor gene deletion in circulating blood using next-generation sequencing.

Chakravadhanula M, Tembe W, Legendre C, Carpentieri D, Liang WS, Bussey KJ, Carpten J, Berens ME, Bhardwaj RD.

J Child Neurol. 2014 Sep;29(9):NP81-5. doi: 10.1177/0883073813503904. Epub 2013 Oct 17.

PMID:
24141276
[PubMed - in process]
5.

Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.

Teng L, Nakada M, Furuyama N, Sabit H, Furuta T, Hayashi Y, Takino T, Dong Y, Sato H, Sai Y, Miyamoto K, Berens ME, Zhao SG, Hamada J.

Neuro Oncol. 2013 Dec;15(12):1710-20. doi: 10.1093/neuonc/not128. Epub 2013 Oct 11.

PMID:
24121831
[PubMed - indexed for MEDLINE]
6.

Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Fortin Ensign SP, Mathews IT, Symons MH, Berens ME, Tran NL.

Front Oncol. 2013 Oct 4;3:241. doi: 10.3389/fonc.2013.00241. Review.

PMID:
24109588
[PubMed]
Free PMC Article
7.

Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.

Dhruv H, Loftus JC, Narang P, Petit JL, Fameree M, Burton J, Tchegho G, Chow D, Yin H, Al-Abed Y, Berens ME, Tran NL, Meurice N.

J Biol Chem. 2013 Nov 8;288(45):32261-76. doi: 10.1074/jbc.M113.493536. Epub 2013 Sep 20.

PMID:
24056367
[PubMed - indexed for MEDLINE]
8.

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation.

Dhruv HD, Whitsett TG, Jameson NM, Patel F, Winkles JA, Berens ME, Tran NL.

Carcinogenesis. 2014 Jan;35(1):218-26. doi: 10.1093/carcin/bgt289. Epub 2013 Aug 23.

PMID:
23975833
[PubMed - indexed for MEDLINE]
9.

Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells.

Dhruv HD, McDonough Winslow WS, Armstrong B, Tuncali S, Eschbacher J, Kislin K, Loftus JC, Tran NL, Berens ME.

PLoS One. 2013 Aug 15;8(8):e72134. doi: 10.1371/journal.pone.0072134. eCollection 2013.

PMID:
23967279
[PubMed - in process]
Free PMC Article
10.

Clinical trials in cellular immunotherapy for brain/CNS tumors.

Badhiwala J, Decker WK, Berens ME, Bhardwaj RD.

Expert Rev Neurother. 2013 Apr;13(4):405-24. doi: 10.1586/ern.13.23. Review.

PMID:
23545055
[PubMed - indexed for MEDLINE]
11.

RTK inhibition: looking for the right pathways toward a miracle.

Xie Q, Vande Woude GF, Berens ME.

Future Oncol. 2012 Nov;8(11):1397-400. doi: 10.2217/fon.12.130.

PMID:
23148613
[PubMed]
12.

The small GTPase RhoG mediates glioblastoma cell invasion.

Kwiatkowska A, Didier S, Fortin S, Chuang Y, White T, Berens ME, Rushing E, Eschbacher J, Tran NL, Chan A, Symons M.

Mol Cancer. 2012 Sep 11;11:65. doi: 10.1186/1476-4598-11-65.

PMID:
22966858
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling.

Creamer MS, Stites EC, Aziz M, Cahill JA, Tan CW, Berens ME, Han H, Bussey KJ, Von Hoff DD, Hlavacek WS, Posner RG.

BMC Syst Biol. 2012 Aug 22;6:107. doi: 10.1186/1752-0509-6-107.

PMID:
22913808
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.

Loftus JC, Ross JT, Paquette KM, Paulino VM, Nasser S, Yang Z, Kloss J, Kim S, Berens ME, Tran NL.

PLoS One. 2012;7(6):e39818. doi: 10.1371/journal.pone.0039818. Epub 2012 Jun 22.

PMID:
22745829
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Stable gene selection from microarray data via sample weighting.

Yu L, Han Y, Berens ME.

IEEE/ACM Trans Comput Biol Bioinform. 2012 Jan-Feb;9(1):262-72. doi: 10.1109/TCBB.2011.47. Epub 2011 Mar 3.

PMID:
21383420
[PubMed - indexed for MEDLINE]
16.

The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.

Nakada M, Anderson EM, Demuth T, Nakada S, Reavie LB, Drake KL, Hoelzinger DB, Berens ME.

Int J Cancer. 2010 Mar 1;126(5):1155-65. doi: 10.1002/ijc.24849.

PMID:
19728339
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The Pyk2 FERM domain as a target to inhibit glioma migration.

Loftus JC, Yang Z, Tran NL, Kloss J, Viso C, Berens ME, Lipinski CA.

Mol Cancer Ther. 2009 Jun;8(6):1505-14. doi: 10.1158/1535-7163.MCT-08-1055. Epub 2009 Jun 9.

PMID:
19509258
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

NHERF-1: modulator of glioblastoma cell migration and invasion.

Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME.

Neoplasia. 2009 Apr;11(4):377-87.

PMID:
19308292
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.

Mikkelsen T, Brodie C, Finniss S, Berens ME, Rennert JL, Nelson K, Lemke N, Brown SL, Hahn D, Neuteboom B, Goodman SL.

Int J Cancer. 2009 Jun 1;124(11):2719-27. doi: 10.1002/ijc.24240.

PMID:
19199360
[PubMed - indexed for MEDLINE]
20.

The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.

Salhia B, Tran NL, Chan A, Wolf A, Nakada M, Rutka F, Ennis M, McDonough WS, Berens ME, Symons M, Rutka JT.

Am J Pathol. 2008 Dec;173(6):1828-38. doi: 10.2353/ajpath.2008.080043. Epub 2008 Nov 13.

PMID:
19008376
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk